Company profile

Belun Technology Company

Clinically Proven Sleep Diagnostics From Diagnosis to Longitudinal Monitoring

Remote Patient Monitoring & Wearables

Company profile

About Belun Technology Company

Belun Technology is a medical device company founded in 2016 that specializes in AI-powered wearable technology for sleep diagnostics and remote patient monitoring. Headquartered in Hong Kong and Singapore with R&D operations in Taiwan, Belun has developed the world's first FDA 510(k)-cleared wearable ring system for obstructive sleep apnea (OSA) diagnosis. The company's flagship Belun Ring captures SpO₂, pulse rate, HRV, and PPG signals overnight, while its proprietary Belun Sleep System uses deep learning algorithms trained on over 200 million PSG data segments to provide comprehensive sleep apnea reports validated against polysomnography. Belun serves healthcare providers, sleep clinics, and patients across multiple markets including the United States, Singapore, Taiwan, India, Thailand, Malaysia, Indonesia, New Zealand, and Australia. The platform addresses a critical global health gap where up to 80% of OSA cases remain undiagnosed due to limited access to traditional in-lab sleep studies. Working closely with medical experts in sleep medicine, cardiology, psychology, and psychiatry, Belun has generated over 150,000 sleep reports worldwide and demonstrated clinical impact including 56% reduction in OSA waiting times. The company's technology supports both individual wellness management and professional medical workflows, enabling scalable sleep diagnostics from diagnosis through longitudinal monitoring and treatment titration.

Company description Belun Technology Company official website

Mission. Shedding light on sleep health through world-class medical wearable technology.

Primary marketRemote Patient Monitoring & Wearables
Commercial modelCommercial information available on request
Company presenceLinkedIn
Work at Belun Technology Company?

Claim this profile to manage Company information and connect with the Health AI Central audience.

Claim this listing

01 · Operating footprint

Where the Company operates

Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.

Clinical focus

  • Cardiovascular complications
  • Comorbid OSA with insomnia
  • Dementia
  • Functional gastrointestinal disorders
  • Gestational metabolic dysfunction
  • Heart failure
  • Hypertension
  • Metabolic syndrome
  • Obstructive Sleep Apnea (OSA)
  • Post-stroke monitoring
  • Sleep disorders

Who it serves

  • Cardiologists
  • Healthcare providers
  • Hospitals
  • Individual consumers
  • Residential care homes
  • Sleep clinics
  • Sleep medicine specialists

Deployment & integration

Cloud Saas · Hybrid deployment with recorded integration context.

Geographic context

MarketsAustralia · Hong Kong · India · Indonesia · Malaysia · New Zealand · Singapore · Taiwan · Thailand · United States
Company sourceOfficial website

Company milestones

Platform expansion

FDA 510(k) clearance for world's first AI-powered wearable ring system for OSA diagnosis; deployment to 60+ residential care homes; generation of 150,000+ sleep reports worldwide

Partnerships

Recorded partners

  • Global sleep labs
  • Hong Kong Young Women's Christian Association
  • Wan Wah Care & Attention Home for the Elderly
  • World-class universities across multiple countries

02 · Flagship portfolio

Products, workflows, and platform capabilities

Selected source-backed Company products and the available commercial context.

Belun remoVital

Continuous vital sign monitoring system for residential care facilities

Platform · Cloud SaaSCompany source

Belun Ring

FDA-cleared wearable ring for medical-grade sleep diagnostics and continuous monitoring

Device · HybridCompany source

Belun Sleep System

World's first AI-powered wearable ring system for OSA diagnosis with sleep staging

Software · Cloud SaaSCompany source

03 · Research intelligence

Research Intelligence evidence

Publications, preprints, clinical validation, and regulatory records in Evidence Position order.

04 · Company-reported outcomes

Outcomes and case studies

Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.

56% reduction in OSA waiting time

104 weeks reduced to 45 weeks (Young et al., Respirology, 2023)

90% success rate in MAD titration

27 days average treatment time (Tozzer et al., AADSM 2025)

150,000+ sleep reports generated

Worldwide deployment across multiple markets

Dental Sleep Medicine Practice (Tozzer et al.)

Mandibular Advancement Device (MAD) titration for sleep apnea treatment

27 days average treatment time with 90% success rate using rapid titration protocol

Clinical Sleep Medicine Practice (Young et al.)

Reducing wait times for OSA diagnosis

56% reduction in OSA waiting time from 104 weeks to 45 weeks

Wan Wah Care & Attention Home for the Elderly (Hong Kong Young Women's Christian Association)

Continuous vital sign monitoring for elderly residents

Deployed to 60+ residential care homes, automated health monitoring with immediate alerts for abnormal vital signs

05 · Leadership

Leadership team

Leadership profiles and professional links from the current Company record.

No active leadership profiles are currently listed.

06 · Company updates

Updates from Belun Technology Company

Recent articles published on Belun Technology Company's official website.

07 · HAIC coverage

Coverage and analysis

Health AI Central reporting that mentions this Company.

No HAIC coverage is currently linked to this Company.

08 · Official presence

Company sources and channels

Curated official destinations from the active Company record.

09 · Market pathway

Additional Companies in this Market

Other active Companies in the same market, selected alphabetically from the HAIC directory.

Market context

Remote Patient Monitoring & Wearables

Companies providing AI-powered remote patient monitoring solutions, wearable health devices with AI analytics, continuous health tracking, or platforms that monitor patients outside clinical settings. Includes general wellness wearables with AI coaching, respiratory monitoring devices, and connected health platforms that aggregate and analyze physiological data from sensors.

Explore the full market directory or compare this Company with additional active profiles.

View all Companies in this market

10 · Pro research

Coming soon

Expanded Company research is in development.

Health AI Central Pro · Coming Soon

Deeper Company research is coming soon.

Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.

ResearchEvidence analysis

Linked research, clinical, and regulatory source pathways.

CompanyTechnical context

Expanded product, deployment, integration, and partnership research.

MethodSource & review record

Record-level provenance and review context.

Coming Soon